12:15 - 1:00 pm
Speaker: Unity Stoakes, Co-Founder & President, StartUp Health
As organizations continue to experiment with new opportunities, driven by marketplace demands and changing customer behaviors, we're starting to see certain trends mature. What does the landscape look like, and where do the greatest opportunities lie?
1:00 - 1:15 pm
1:15 - 1:45 pm
An Ongoing Process of Improvement: Using Analytics to Make Smarter Business Decisions and Prescribe Effective Engagement
Speaker: Marilyn Cox, Marketing Principal, Industry Center of Excellence, Oracle Marketing Cloud
Multichannel, Omnichannel, Cross-channel.... Call it what you want but it all means the same thing. Challenge. An unrealistic expectation of perfection.
We recognize that communication channels are multiplying. Marketing teams are tasked with communicating a consistent value message across email campaigns, direct mail campaigns, print and digital ads, social media, websites, blogs, events, press releases, partner and patient portals, and on and on and on......
And with that comes the multiplication of audiences. You have physicians, pharmacists, payors, and patients. And each of those has a sphere of influence that's hard to define. Oh, and you need to do that all the while remaining compliant and often with little budget.
But it's these expansive audiences and communication channels that ultimately carry your value message. You can't ignore them. You must engage.
In this presentation we'll discuss how to:
- Effectively engage across complex channels and spheres of influence; drive new forms of engagement with "hard to see" and "no see" physicians
- Collect and analyze data and metrics to make smarter business decisions
- Empower sales to effectively engage prescribers and payors; amplify the voice of thought leading payer formulary influencers
1:45 - 2:00 pm
Speaker: Sara Holoubek, Founder & CEO, Luminary Labs
Through partnerships and acquisitions, pharma companies have started exploring technologies, products and platforms as a growth strategy to complement "the pill". A range of companies are developing sensors, telepresence tools and other technologies that will be embedded into the environment, and take advantage of data collected from smart phones, wearables and other devices to drive better health outcomes. How and where can pharma participate?
2:45 pm - 2:55 pm
2:55 - 3:05 pm
Building Long-Term Relationships in Healthcare
Speaker: Aubrey Wing, Senior Solutions Consultant, Marketo
With regulatory changes in healthcare adding complexity to the marketing landscape, marketers face growing challenges such as minimizing costs, maximizing efficiencies, leveraging IT for a competitive advantage, and many more!
Join this webinar to discover how Marketo can help you tackle this changing landscape through truly personalized and integrated marketing. We'll specifically discuss strategic initiatives in the Healtchare industry, including how to:
- Enhance marketing efficiency
- Increase your number of qualified targets (members, patients, physicians, etc.)
- Engage your audience early
- Reduce attrition
- Enable multi-channel marketing
3:05 - 3:20 pm
3:20 - 4:05 pm
CRM Re-Imagined: Moving to a Centralized Multi-Channel Marketing Platform
Speaker: Craig DeLarge, Global Leader, Multichannel Marketing Strategy & Innovation, Merck & Co.
How can we move beyond antiquated email blasts to an analytics-led centralized program that drives targeted engagement at each touch point along the customer journey? Marketing automation software offers a big opportunity for pharma marketers to take CRM, channel integration and customer analytics to the next level.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.